However, antimiR-29b could restore PGC-1α, and ameliorate podocyte injury and renal fibrosis, suggesting antimiR-29b could regulate PGC-1α levels at a normal or suitable level. The gene discussed is PPARGC1A; the disease is renal fibrosis.